InspireMD is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) designed for delivering neurovascular protection and stroke prevention. InspireMD is dedicated to the development of advanced technologies and seeks to utilize its proprietary MicroNet™ technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes through a proprietary stent platform, CGuard™ EPS. CGuard brings to the world the only carotid stent platform with patented MicroNet™ mesh technology designed to reduce stroke during and after CAS. InspireMD (NSPR) is traded on NASDQ Capital Markets.
View Top Employees from InspireMDWebsite | http://www.inspiremd.com |
Ticker | NSPR |
Revenue | $3 million |
Funding | $11 million |
Employees | 71 (71 on RocketReach) |
Founded | 2005 |
Address | 4 MENORAT HAMAOR St, Tel Aviv, Tel Aviv, IL |
Phone | +972 3-691-7691 |
Fax | +972 3-691-7692 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Medical Device, Medical Devices, Medical Devices & Equipment, Biopharma, Medical Supplies, Manufacturing, Biotechnology, Other Devices and Supplies, Stents, Health Care, Science and Engineering |
Web Rank | 12 Million |
Keywords | Nspr, Inspiremd Press Releases |
Competitors | Allium Ltd, Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.], Keystone Heart, A Venus Medtech Company, STENTYS, Sahajanand Medical Technologies |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular InspireMD employee's phone or email?
The InspireMD annual revenue was $3 million in 2024.
Craig Shore is the CFO of InspireMD.
71 people are employed at InspireMD.
InspireMD is based in Tel Aviv, Tel Aviv.
The NAICS codes for InspireMD are [339, 33].
The SIC codes for InspireMD are [38, 384].